Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Finance Today.
Press releases published on June 6, 2025

Captivision, Inc. Announces Receipt of Staff Determination Letter from Nasdaq
MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, announced that on June 4, 2025, it received a staff determination letter (the “ …

Broadway Technology Inc Announces Entering into a Merger Agreement with Quartzsea Acquisition Corporation
HAINING, China, June 06, 2025 (GLOBE NEWSWIRE) -- Broadway Technology Inc (“Gaokai”), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its operating subsidiary Zhejiang Gaokai New Materials Co., Ltd., announced …

Magnetic North Acquisition Corp. Provides Bi-Weekly Update On Status Of Management Cease Trade Order
CALGARY, Alberta and TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) is providing this bi-weekly update on the status of the management cease trade order granted on May 9 …

Opendoor Announces Preliminary Proxy Filing Seeking Approval for Discretionary Reverse Stock Split
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN) (the “Company,” “Opendoor,” “we,” “our” or “us”), a leading e-commerce platform for residential real estate transactions, filed a preliminary proxy statement. The …

SRQ Resources Announces Results of AGM
MONTREAL, June 06, 2025 (GLOBE NEWSWIRE) -- SRQ Resources Inc. (TSX-V: SRQ) (“SRQ” or the “Company”) today announces that all nominees listed in the management proxy circular were elected as directors of the Company at its annual general meeting of …

Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to July 9, 2025
New York, NY , June 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on June 5, 2025, it caused to be deposited $0.15 …

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 14 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 6, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Northann Corp. Issues Statement on Recent Stock Volatility
Fort Lawn, SC, June 06, 2025 (GLOBE NEWSWIRE) -- Northann Corp. (“Northann” or the “Company”) (NYSE American: NCL), a company specializing in 3D printing and manufacturing solutions, today announced that it is not aware of any new material developments or …

NIRI Florida Announces its 2025-2026 Board of Directors
Fort Lauderdale, FL, June 06, 2025 (GLOBE NEWSWIRE) -- The Florida Chapter of NIRI: The Association for Investor Relations is pleased to announce the election of the following individuals to serve on the Board of Directors for the 2025-2026 program year: …

Camwood Capital Group Names Co-Founder Matt Mayfield as President and CEO in Strategic Leadership Move
AUSTIN, TX, June 06, 2025 (GLOBE NEWSWIRE) -- Matt Mayfield Camwood Capital Group (“Camwood”), a private investment firm focused on long-term value creation in industrial sectors and specializing in lower middle-market companies, has officially named co- …

XOVR ETF Adds Anduril, Joining SpaceX to Offer Pre-IPO Access
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- ERShares, the first Crossover ETF that offers retail investors access to Private companies, with SpaceX as its top weight, is ushering in the next generation of investing with a new private equity position in …

OBI Pharma geht AWK-Zusammenarbeit mit TegMine Therapeutics bei der Nutzung von GlycOBI® und TegMiner™ Enabling Technologies ein
TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), ein globales, im klinischen Stadium tätiges Onkologieunternehmen, das auf die Entwicklung neuartiger Krebstherapien wie Antikörper-Wirkstoff-Konjugate (AWK) (4174. TWO) spezialisiert …

Collaboration entre OBI Pharma et TegMine Therapeutics autour des ADC, reposant sur les technologies habilitantes GlycOBI® et TegMiner™
TAIPEI, Taïwan, 06 juin 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), une société internationale d’oncologie au stade clinique, spécialisée dans le développement de nouvelles thérapies contre le cancer, telles que les conjugués anticorps-médicaments ( …

Toobit Wins Digital Asset Derivatives Platform of the Year at Hedgeweek Global Digital Assets Awards 2025
GEORGE TOWN, Cayman Islands, June 06, 2025 (GLOBE NEWSWIRE) -- Toobit, a leading global cryptocurrency exchange, today wins the title of Digital Asset Derivatives Platform of the Year at the Hedgeweek Global Digital Assets Awards 2025, announced during the …

Cycurion Announces Continued Listing and Trading of its Common Stock and Warrants on NASDAQ
MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces continued listing and trading of its shares of common stock and warrants on NASDAQ. …